For years, Pfizer was the only drugmaker with treatments for the disease, called ATTR-CM, but BridgeBio’s CEO said in an ...

Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds. Usha Lee McFarling ...

Here are eight possible indicators of how health secretary Robert F. Kennedy Jr. may handle U.S. vaccine policy in coming ...

Focusing on companies including Adidas, H&M, Ikea, and Inditex and analysing corporate strategy, consumer trends, and regulatory changes, Helen also covers major supermarket groups like Ahold ...

Earlier this month, the FDA delayed a decision on whether to grant full approval to Novavax’s Covid-19 vaccine, and over the ...

Confusion over the FDA delay in granting full approval to Novavax’s Covid-19 vaccine deepened over the weekend, with possible ...

STAT senior writer Helen Branswell reflects on the trajectory of the Covid-19 pandemic: about the wishful thinking that led ...

In today's Morning Rounds newsletter, HHS axes an autism registry, the Trump presidency approaches 100 days, and funding for ...

Some key public health figures are taking an extraordinary step to try to shore up U.S. vaccination policy, feared to be ...

The Advisory Committee on Immunization Practices voted Wednesday to recommend lowering the age at which adults can get a ...

Daniel Payne reports on how the health industry and Washington influence and impact each other. He joined STAT in 2025 after covering health care at POLITICO. You can reach Daniel on Signal at ...